R&D
Thermo and the Michael J. Fox Foundation Map 5,500 Samples to Hunt Parkinson’s Biomarkers
A large proteomics analysis of a landmark Parkinson’s study is now public, aiming to sort patients into subtypes and speed more targeted, biology-driven therapies.